Integra Lifesciences Holdings (IART) Other Working Capital Changes (2009 - 2026)
Integra Lifesciences Holdings (IART) reported Other Working Capital Changes of $369000.0 for Q1 2026, up 51.23% on a YoY basis from $244000.0 in Q1 2025, and down 46.13% sequentially from $685000.0 in Q4 2025.
Integra Lifesciences Holdings (IART) Other Working Capital Changes (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings (IART) has 16 years of Other Working Capital Changes data on file, last reported at $369000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 51.23% year-over-year to $369000.0; the trailing twelve-month figure through Mar 2026 stood at $3.5 million (up 85.92% YoY), and the FY2025 full-year result was $3.4 million, down 3.95% from the prior year.
- Other Working Capital Changes eased to $369000.0 in Q1 2026, from $685000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $22.7 million in Q2 2025 to a low of -$16.2 million in Q3 2025.
- A 5-year average of $1.9 million and a median of $2.2 million in 2023 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 3936.14% in 2022, while the deepest fall reached 3003.61% in 2022.
- Tracing IART's Other Working Capital Changes over 5 years: stood at $1.8 million in 2022, then plunged by 131.49% to -$551000.0 in 2023, then soared by 411.8% to $1.7 million in 2024, then plunged by 60.13% to $685000.0 in 2025, then slumped by 46.13% to $369000.0 in 2026.
- Business Quant data shows IART's Other Working Capital Changes at $369000.0 in Q1 2026, $685000.0 in Q4 2025, and $371000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Integra Lifesciences Holdings | 1.71 Bn | 1.45 Bn | 216.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.88 Mn |
| Mar 31, 2026 | 21.88 Mn |
| Mar 31, 2026 | 21.88 Mn |
| Dec 31, 2025 | -2.19 Mn |
| Dec 31, 2025 | -2.19 Mn |
| Dec 31, 2025 | -2.19 Mn |
| Sep 30, 2025 | -16.22 Mn |
| Sep 30, 2025 | -16.22 Mn |
| Sep 30, 2025 | -16.22 Mn |
| Jun 30, 2025 | 22.73 Mn |
| Jun 30, 2025 | 22.73 Mn |
| Jun 30, 2025 | 22.73 Mn |
| Mar 31, 2025 | -1.51 Mn |
| Mar 31, 2025 | -1.51 Mn |
| Mar 31, 2025 | -1.51 Mn |
| Dec 31, 2024 | 6.44 Mn |
| Dec 31, 2024 | 6.44 Mn |
| Dec 31, 2024 | 6.44 Mn |
| Sep 30, 2024 | -15.03 Mn |
| Sep 30, 2024 | -15.03 Mn |